Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation

Pediatric Hematology and Oncology

Volumn 20, Issue 2, 2003, Pages 151-155

  Misawa, Akiko ^a   Hosoi, Hajime ^a   Tsuchiya, Kunihiko ^a   Iehara, Tomoko ^a   Sawada, Tadashi ^a   Sugimoto, Tohru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Allogeneic stem cell transplantation; Graft versus tumor effect; Rhabdomyosarcoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; METHYLPREDNISOLONE; MYELOABLATIVE AGENT; PIRARUBICIN; VINCRISTINE;

ADOLESCENT; ALLOTRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DIARRHEA; DISEASE COURSE; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; RHABDOMYOSARCOMA; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DISEASE PROGRESSION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FATAL OUTCOME; FEMALE; GRAFT VS TUMOR EFFECT; HEAD AND NECK NEOPLASMS; HUMANS; IFOSFAMIDE; IMMUNOSUPPRESSIVE AGENTS; NEOPLASM RECURRENCE, LOCAL; NIMUSTINE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RHABDOMYOSARCOMA; TRANSPLANTATION CONDITIONING; VINCRISTINE;

EID: 0037367906     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/0880010390158658     Document Type: Article

References (6)

1. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the intergroup rhabdo-myosarcoma study group. J Clin Oncol. 1999;17:3487-3493.
2. Ueno NT, Rondon G, Mirza NQ, et al. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol. 1998;16:986-993.
3. Childs R, Chernoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 2000;343:750-758.
4. Bay JO, Choufi B, Pomel C, et al. Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer. Bone Marrow Transplant. 2000;25:681-682.
5. Martin PJ, Clift RA, Fisher LD, et al. HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood. 1988;72:1978-1984.
6. Carli M, Colombatti R, Ogerlin O, et al. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma. J Clin Oncol. 1999;17:2796-2803.